Press release
COVID-19: Potential Impact on Top 10 Cancer Drugs Market Value to grasp $129.94 billion by 2026 | AbbVie Inc., Astellas Pharma Inc
Top 10 Cancer Drugs Market
Global Top 10 Cancer Drugs Market Report provides an overview of the market based on key parameters such as market size, sales, sales analysis and key drivers. The market size of the market is expected to grow on a large scale during the forecast period (2019-2026). This report covers the impact of the latest COVID-19 on the market. The coronavirus epidemic (COVID-19) has affected all aspects of life around the world. This has changed some of the market situation. The main purpose of the research report is to provide users with a broad view of the market. Initial and future assessments of rapidly changing market scenarios and their impact are covered in the report.
Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/6225
Cancer caused when the cells present in the body grow at an uncontrolled rate leading to the formation of a tumor. Cancer has different stages based on its progression. Metastasis is the final stage of the disease, which is marked by the invasion of tumor into others parts of body. The management of cancer in patients requires the use of different forms of drugs such as hormonal therapy, immunotherapy, targeted therapy, and others.
Drugs such as Revlimid, Opdivo, Keytruda, Herceptin, Avastin, Rituxan, Imbruvica, Neulasta/Peglasta, Ibrance, and Zytiga are the top selling drugs in 2018. The key drivers of the global cancer drugs market are increase in incidence of cancer, rise in adoption of advance therapies such as biological & targeted drug therapies, surge in geriatric population, and rise in collaborations & partnerships to facilitate drug development. In addition, availability of the drugs and increase in healthcare expenditure have significantly contributed toward the growth of this market. Increase in number of pipeline drugs along with high potential of emerging economies are further expected to provide lucrative opportunities for market expansion. However, high cost involved in new drug development and adverse effects related to cancer drugs are expected to impede the market growth.
The global top 10 cancer drugs sales is segmented on the basis of region. Regionally, the market is studied across Europe (Russia, Netherlands, Switzerland, Sweden, Belgium, Austria, Norway, Denmark, Poland, Finland, Portugal, Greece, Ireland, Czech Republic, Hungary, Romania, Ukraine), Asia-Pacific (Taiwan, Indonesia, New Zealand, Singapore, Malaysia, Vietnam, Myanmar, Sri Lanka, Macau, Nepal), and LAMEA (Turkey, Venezuela, Colombia, Argentina, Iran, Israel, Chile, Algeria, United Arab Emirates, Puerto Rico, Morocco, Costa Rica, Lebanon).
In the current scope of the study, Europe was the leading revenue contributor to the market in 2018, owing to high adoption rate of cancer drugs. However, Asia-Pacific is expected to grow at the highest CAGR from 2019 to 2026, owing to increase in adoption of advanced therapies, surge in research, development, & innovation activities; and rise in awareness related to different cancers.
Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/6225
The Major Key Players Are:
• AbbVie Inc.
• Astellas Pharma Inc.
• AstraZeneca PLC
• Bristol-Myers Squibb Company
• Celgene Corporation
• F. Hoffmann-La Roche Ltd.
• Johnson & Johnson (Janssen Global Services, LLC,)
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
Key Findings of the Top 10 Cancer Drugs Market:
• Revlimid occupied 15.22% share of the global top 10 cancer drugs sales in 2018.
• Keytruda is anticipated to grow at the highest rate during the analysis period.
• The Europe cancer drugs accounted for 21.21% share of the global top 50 cancer drugs sales in 2018.
• The top 10 cancer drugs accounted for 52.96% share of the global top 50 cancer drugs sales in 2018.
• Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA
Contact:
David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
About Us
Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release COVID-19: Potential Impact on Top 10 Cancer Drugs Market Value to grasp $129.94 billion by 2026 | AbbVie Inc., Astellas Pharma Inc here
News-ID: 2107957 • Views: …
More Releases from Allied Market Research
Hotel Toiletries Market Revenue is expected to Surpass $50.5 billion by 2031
The hotel toiletries market was valued at $17.9 billion in 2021, and is estimated to reach $50.5 billion by 2031, growing at a CAGR of 10.8% from 2022 to 2031.
Get Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/75060
There is a greater demand for hotel toiletries with the growth of the tourism industry and the rise in international travel. Improved transportation, economic growth, globalization, technology advancements, and other initiatives have…
False Lashes Market to Grow at a CAGR of 6.5% and will Reach USD 2.4 billion by …
According to a new report published by Allied Market Research, titled, "False Lashes Market," The false lashes market size was valued at $1.3 billion in 2021, and is estimated to reach $2.4 billion by 2031, growing at a CAGR of 6.5% from 2022 to 2031.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/6826
False lashes are for people with short or thin eyelashes. They consist of synthetic or human…
Tourism Source Market Size Worth USD 1.1 Trillion by 2032 | Growth Rate (CAGR) o …
The Tourism Source Market Size was valued at $599.40 billion in 2022, and is estimated to reach $1.1 Trillion by 2032, growing at a CAGR of 6.6% from 2023 to 2032.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/6807
Traveling to other locations for pleasure, recreation, or business is referred to as tourism. It entails travelling to and taking in a variety of locations, points of interest, and cultural…
Music Event Market is poised to reach USD 775.7 billion, growing at a 10.2% CAGR …
The music event market size was valued at $250.80 billion in 2023, and is estimated to reach $775.7 billion by 2035, growing at a CAGR of 10.2% from 2024 to 2035.
Get Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/A08029
Music events are live or virtual gatherings where performers showcase their musical talent to audiences, serving as a pillar of the entertainment industry. These events have various formats,…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
